Skip to main content
. 2013 Dec 11;11:303. doi: 10.1186/1479-5876-11-303

Figure 2.

Figure 2

Effects on osteoclasts. Osteoclasts release BPs from the bone matrix. N-containing BPs potently inhibit farnesyl pyrophosphate synthase (FPPS), a key enzyme in the mevalonate/cholesterol biosynthetic pathway. Non-N-BPs are incorporated metabolically into non-hydrolyzable cytotoxic analogs of ATP (AppCp).